Everything You Want to Know About PARP Inhibitors

PARP inhibitors have revolutionized ovarian cancer treatment and provided hope for so many patients. At the same time, a lot of questions often come up about their use: when should they be used? How long can they be taken for? PARP after PARP? Dr. Kathleen Moore, Director of the Oklahoma TSET Phase I Program at Stephenson Cancer Center, will provide an overview of PARP inhibitors and what the latest research shows. If you have questions about PARP inhibitors, this program is for you!



Register to get instructions to join.

Thursday, 3-4pm ET
September 2

Register Online

National Helpline: